«Дарниця» представила інвестиційні проєкти на Міжнародній конференції з відновлення України

PJSC “FITOFARM” continues to resume production of its drugs. The company concluded an agreement on contract production with a new partner – PE “KILAFF”. The “KILAFF” company is a reliable…

Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…